Background: Only a few international studies have assessed the economic burden of atopic dermatitis (AD), and no costs-of-illness study for AD has been done for the Netherlands.
Objectives: To estimate the incidence, prevalence and health-care costs of AD in the Netherlands and to put these in an international perspective.
Methods: We conducted a retrospective cohort study by using the data of an information system of general practitioners (GPs).